NCT01838083View on ClinicalTrials.gov

Euglycemic Clamp Study Comparing Two New Insulin Glargine Formulations in Subjects With Type 1 Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Type1 Diabetes
Interventions
DRUG

Insulin glargine new formulation HOE901

Pharmaceutical form: solution Route of administration: subcutaneous

Trial Locations (1)

41460

Investigational Site Number 276001, Neuss

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT01838083 - Euglycemic Clamp Study Comparing Two New Insulin Glargine Formulations in Subjects With Type 1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter